I am a medical epidemiologist (MD in 1988 at Paris V, specialisation in rheumatology in 1990, Paris V, and DrPH from Harvard School of Public Health in 1993) specialized in infectious diseases epidemiology. After working at WHO at the clinical research unit of the Global Program on AIDS (1993-1994), I spent five years in Ethiopia and two years in the Netherlands working as the Program Manager of the Ethio-Netherlands AIDS Research Project (1994-2001). In 2002, I joined Institut Pasteur to launch the Emerging Diseases Epidemiology unit. There, my focus has been on viral hepatitis C (North-Coordinator of the ANRS research site on viral hepatitis; www.hepnile.org) and emerging infections such as the SARS (Scientific Coordinator of the EPISARS project which aimed prevent the re-emergence of SARS through the control of its animal reservoir) and the MERS-CoV. I also have a strong teaching involvement, as co-Director and founder of the Pasteur-Cnam School of Public Health (http://ecole-pasteur.cnam.fr), and coordinator of a master in public health with strong focus on infectious diseases. In 2014, I was appointed as Director of the newly created Pasteur Centre for Global Health Research and Education.
Cliquez pour voir le graph
Connexions
Cliquez pour voir la ligne de temps
Ligne de temps
Projets Transversaux
Projets
Publications
Télécharger-
2021Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies., Cell Rep Med 2021 Apr; (): 100275.
-
2021SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review., BMJ Open 2021 04; 11(4): e045425.
-
2021Systematic Booster after Rabies Pre-Exposure Prophylaxis to Alleviate Rabies Antibody Monitoring in Individuals at Risk of Occupational Exposure., Vaccines (Basel) 2021 Mar; 9(4): .
-
2021Prevalence of congenital microcephaly and its risk factors in an area at risk of Zika outbreaks., BMC Pregnancy Childbirth 2021 Mar; 21(1): 214.
-
2021SARS-CoV-2 variants and ending the COVID-19 pandemic., Lancet 2021 03; 397(10278): 952-954.
-
2021A Self-Assessment Web-Based App to Assess Trends of the COVID-19 Pandemic in France: Observational Study., J Med Internet Res 2021 03; 23(3): e26182.
-
2021Sex differences in the evolution of neutralizing antibodies to SARS-CoV-2., J Infect Dis 2021 Mar; (): .
-
2021Reassessment of the risk of birth defects due to Zika virus in Guadeloupe, 2016., PLoS Negl Trop Dis 2021 Mar; 15(3): e0009048.
-
2021Covid-19: Keeping schools as safe as possible., BMJ 2021 02; 372(): n524.
-
2021Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study., Lancet Microbe 2021 Feb; 2(2): e60-e69.
-
+Voir la liste complète de publications